Frontlight ResearchEarly access
Trial site
CARE - Centro de Alergia y Enfermedades Respiratorias
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Type 2 diabetes3 trials
- Asthma2 trials
- Atopic dermatitis (eczema)1 trial
- COPD1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 34 trials
- Phase 23 trials
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Upstream Bio Inc.3 trials
- Amgen1 trial
Running trials
Active, not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Active, not recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026